A phase II, open-label study of ONC201 in adults with recurrent high-grade glioma

Project: Research project

Description

A phase II, open-label study of ONC201 in adults with recurrent high-grade glioma
StatusActive
Effective start/end date3/12/193/30/24

Funding

  • ONCOCEUTICS, INC.

Fingerprint

Glioma
TIC10 compound